Cognitive Bias Modification for Interpretation (CBM-I) in People With Type 2 Diabetes and Persistent Pain

Summary

The goal of this clinical trial is to examine the efficacy of cognitive bias modification for interpretation (CBM-I) in people with Type 2 Diabetes and persistent pain. The main question\[s\] it aims to answer is whether interpretation bias training away from pain improves pain outcomes. Participants in the CBM-I group will complete 4 online training sessions approximately half an hour each. Each session will present participants with ambiguous scenarios which may be pain-related, however the final word of the sentence will resolve the scenario as benign (thus training participants to make benign interpretations). A measure of interpretation bias will be administered following the fourth training session, and pain severity and interference will be measured at baseline, post-training, two week follow up, and three month follow up. The study hypothesises that participants in the CBM-I group will demonstrate a greater reduction in the co-primary outcomes of pain severity and pain interference over time compared to those in the placebo control.

Eligibility

Inclusion Criteria:

* Over 18 years of age
* Have a diagnosis of Type 2 diabetes.
* Have persistent pain (pain present on more days than not, for 3 months or longer).
* Score ≥ 3 on average pain severity on the Brief Pain Inventory (BPI).
* Fluent in English
* Have access to internet and ability to use a computer over a three month period.

Exclusion Criteria:

* Under 18 years of age
* No diagnosis of Type 2 diabetes
* No persistent pain
* Not fluent in English
* No access to internet nor ability to use a computer.

Conditions3

Browse More Trials